Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy
Plain-language summaries of 10,888 rare conditions, drawn from MONDO, GeneReviews, ClinVar, FDA, NIH, ClinicalTrials.gov, PubMed, and 5 other public sources. Free, sourced, never gated.
Kisho provides public health information only — not medical advice. Always consult your healthcare provider.
12
authoritative sources — clinical, regulatory, scientific
10,888
rare conditions, continuously monitored
Daily
updates from MONDO, HPO, ClinicalTrials.gov, FDA, Orphanet…
Showing 3,581-3,600 of 10,888 diseases
MONDO:0013661
Combined malonic and methylmalonic acidemia is an inborn error of metabolism that leads to the accumulation of malonic acid and methylmalonic acid in...
MONDO:0030854
Combined osteogenesis imperfecta and Ehlers-Danlos syndrome 1 is a complex connective tissue disorder that presents with features overlapping both ost...
MONDO:0030855
Combined osteogenesis imperfecta and Ehlers-Danlos syndrome 2 is a connective tissue disorder that primarily affects the bones, skin, and other suppor...
MONDO:0013969
Combined oxidative phosphorylation defect type 11 is a condition that disrupts the body’s energy production due to mutations in the RMND1 gene. It aff...
MONDO:0013977
Combined oxidative phosphorylation defect type 13 is a rare mitochondrial disorder that affects energy production and muscle function. It is caused by...
MONDO:0013986
Combined oxidative phosphorylation defect type 14 is a severe metabolic disorder that affects multiple organ systems, with a primary impact on the bra...
MONDO:0013987
Combined oxidative phosphorylation defect type 15 is a mitochondrial disorder that affects energy production in cells. It is caused by pathogenic vari...
MONDO:0014190
Combined oxidative phosphorylation defect type 17 is a disorder of mitochondrial energy metabolism caused by mutations in the ELAC2 gene. It typically...
MONDO:0012510
Combined oxidative phosphorylation defect type 2 is a severe mitochondrial disorder that affects multiple systems from the earliest stages of developm...
MONDO:0014397
Combined oxidative phosphorylation defect type 20 is a severe multisystem disorder affecting several organs, including the brain, heart, and muscles....
MONDO:0014398
Combined oxidative phosphorylation defect type 21 is a very rare mitochondrial condition that primarily affects energy production in cells. It results...
MONDO:0014525
Combined oxidative phosphorylation defect type 23 is a condition that affects cellular energy production by impairing the mitochondrial oxidative phos...
MONDO:0014547
Combined oxidative phosphorylation defect type 24 is a condition affecting energy production in cells due to abnormalities in mitochondrial function....
MONDO:0014636
Combined oxidative phosphorylation defect type 25 is a condition in which the body’s ability to produce energy is impaired due to a mutation in the MA...
MONDO:0014684
Combined oxidative phosphorylation defect type 26 is a multisystem disorder caused by pathogenic variants in the TRMT5 gene that impair mitochondrial...
MONDO:0014728
Combined oxidative phosphorylation defect type 27 is a very rare multisystem disorder caused by mutations in the CARS2 gene, which is essential for mi...
MONDO:0014856
Combined oxidative phosphorylation defect type 30 is a severe disorder affecting mitochondrial energy production, caused by mutations in the TRMT10C g...
MONDO:0012534
Combined oxidative phosphorylation defect type 4 is a rare mitochondrial disorder that affects energy production in multiple organ systems. It is caus...
MONDO:0013306
Combined oxidative phosphorylation defect type 7 is a rare mitochondrial condition that affects energy production in cells, particularly impacting the...
MONDO:0013570
Combined oxidative phosphorylation defect type 8 is a mitochondrial disorder that impairs the production of essential energy in cardiac, skeletal musc...
Built from MONDO, HPO, ClinicalTrials.gov, FDA, Orphanet, and 7 more public sources. Updated daily.